The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) advances the policy, science, and practice of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being, including clinical, economic, and patient-centered outcomes). With a commitment to education, collaboration, and leadership, ISPOR meetings, published resources, and facilitated discussions have evolved as the leading global resources for health economics and outcomes research. With 9,500 individual and student members from 114 countries, and over 8,700 affiliate members from Regional Chapters, ISPOR represents the entire field including research, academia, decision and policy makers, consultants, payers and patient representative groups.
- President: Lindsay Petrenchik
- President Elect: Joyce Oh
- Secretary: Jennifer Tsan
- Treasurer: Nicholas Dickson